AI-Designed Vaccine Offers Hope for Broad Protection Against Future Viruses
New AI-designed ‘universal vaccine’ could future-proof humans against unknown viruses
Euronews
Image: Euronews
Researchers from the universities of Cambridge and Southampton have developed the first AI-designed vaccine tested in humans, aimed at providing broad protection against evolving viruses like coronaviruses and Ebola. This innovative vaccine, administered without needles, could revolutionize future immunization strategies.
- 01The vaccine was developed using AI to create a 'super-antigen' that mimics features across multiple coronaviruses.
- 02The delivery method involves a microfluidic jet, eliminating the need for needles and enhancing global accessibility.
- 03The initial trial included 39 volunteers and reported no significant safety concerns, paving the way for further research.
- 04This vaccine aims to provide lasting protection against both current and future viral mutations.
- 05Researchers plan to initiate a phase 2 clinical trial to evaluate immune responses in a larger, more diverse group.
Advertisement
In-Article Ad
A team of researchers from the universities of Cambridge and Southampton has created the first vaccine designed entirely by artificial intelligence (AI) to be tested on humans. This innovative vaccine targets a range of viruses, including coronaviruses and Ebola, aiming to provide broader protection against evolving pathogens. Professor Saul Faust, the trial's chief investigator, highlighted the limitations of current reactive vaccine systems, which struggle to keep pace with rapidly mutating viruses. The AI-designed vaccine utilizes a 'super-antigen' that triggers the immune system to recognize multiple viral strains. Notably, it is administered via a microfluidic jet, eliminating the need for needles and making it more suitable for low-resource settings. The initial trial, conducted between December 2021 and September 2023, involved 39 participants and reported no significant safety issues. Following these promising results, researchers will advance to a phase 2 clinical trial to further assess the vaccine's efficacy in a broader population.
Advertisement
In-Article Ad
The AI-designed vaccine could significantly enhance global vaccination efforts by providing broader protection against emerging viruses.
Advertisement
In-Article Ad
Reader Poll
What do you think about the potential of AI-designed vaccines?
Connecting to poll...
More about University of Cambridge

AI-Designed Vaccine Shows Promise in Human Trials for Future Pandemic Prevention
Gulf News • Jun 5, 2026

Cambridge Researchers Create First AI-Designed Vaccine Against Coronaviruses
The Indian Express • Jun 5, 2026

First Human Trial of Universal Sarbeco Coronavirus Vaccine Shows Promising Safety Results
Medical News • Jun 5, 2026
Read the original article
Visit the source for the complete story.

